Shockwave Medical Inc
NASDAQ:SWAV
Shockwave Medical Inc
Cash Equivalents
Shockwave Medical Inc
Cash Equivalents Peer Comparison
Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Shockwave Medical Inc
NASDAQ:SWAV
|
Cash Equivalents
$281.7m
|
CAGR 3-Years
70%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash Equivalents
$2.3B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
28%
|
CAGR 10-Years
3%
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash Equivalents
$2.3B
|
CAGR 3-Years
5%
|
CAGR 5-Years
76%
|
CAGR 10-Years
28%
|
|
Stryker Corp
NYSE:SYK
|
Cash Equivalents
$2.3B
|
CAGR 3-Years
1%
|
CAGR 5-Years
7%
|
CAGR 10-Years
5%
|
|
Abbott Laboratories
NYSE:ABT
|
Cash Equivalents
$6.3B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
16%
|
CAGR 10-Years
12%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash Equivalents
$2.2B
|
CAGR 3-Years
39%
|
CAGR 5-Years
29%
|
CAGR 10-Years
11%
|
See Also
What is Shockwave Medical Inc's Cash Equivalents?
Cash Equivalents
281.7m
USD
Based on the financial report for Mar 31, 2024, Shockwave Medical Inc's Cash Equivalents amounts to 281.7m USD.
What is Shockwave Medical Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
15%
Over the last year, the Cash Equivalents growth was 0%. The average annual Cash Equivalents growth rates for Shockwave Medical Inc have been 70% over the past three years , 15% over the past five years .